Table 1.
Baseline characteristics of patients enrolled in the study.
| Characteristic | Overall (n = 260) | Standard care (n = 88) | Reminder app (n = 82) | Smart pillbox (n = 90) | p-valuea |
|---|---|---|---|---|---|
| Sex | 0.761 | ||||
| Female | 85 (32.7%) | 28 (31.8%) | 25 (30.5%) | 32 (35.6%) | |
| Male | 175 (67.3%) | 60 (68.2%) | 57 (69.5%) | 58 (64.4%) | |
| Age, years | |||||
| Median (IQR) | 32 (25, 50) | 30 (26, 53) | 26 (24, 33) | 44 (31, 65) | <0.001 |
| 18–29 | 114 (43.8%) | 42 (47.7%) | 52 (63.4%) | 20 (22.2%) | <0.001 |
| 30–44 | 65 (25.0%) | 16 (18.2%) | 22 (26.8%) | 27 (30.0%) | |
| 45–59 | 33 (12.7%) | 14 (15.9%) | 4 (4.9%) | 15 (16.7%) | |
| > = 60 | 48 (18.5%) | 16 (18.2%) | 4 (4.9%) | 28 (31.1%) | |
| Migrant | <0.001 | ||||
| No | 86 (33.1%) | 21 (23.9%) | 16 (19.5%) | 49 (54.4%) | |
| Yes | 174 (66.9%) | 67 (76.1%) | 66 (80.5%) | 41 (45.6%) | |
| Completed high school | 0.224 | ||||
| No | 106 (40.8%) | 34 (38.6%) | 29 (35.4%) | 43 (47.8%) | |
| Yes | 154 (59.2%) | 54 (61.4%) | 53 (64.6%) | 47 (52.2%) | |
| Marital status | <0.001 | ||||
| Married | 158 (60.8%) | 56 (63.6%) | 34 (41.5%) | 68 (75.6%) | |
| Single | 102 (39.2%) | 32 (36.4%) | 48 (58.5%) | 22 (24.4%) | |
| Occupation | 0.006 | ||||
| Student or employed | 197 (75.8%) | 70 (79.5%) | 69 (84.1%) | 58 (64.4%) | |
| Unemployed or retired | 63 (24.2%) | 18 (20.5%) | 13 (15.9%) | 32 (35.6%) | |
| Insured | <0.001 | ||||
| No | 89 (34.2%) | 40 (45.5%) | 39 (47.6%) | 10 (11.1%) | |
| Yes | 171 (65.8%) | 48 (54.5%) | 43 (52.4%) | 80 (88.9%) | |
| Reimbursement policy covered | <0.001 | ||||
| No | 114 (43.8%) | 52 (59.1%) | 45 (54.9%) | 17 (18.9%) | |
| Yes | 146 (56.2%) | 36 (40.9%) | 37 (45.1%) | 73 (81.1%) | |
| Number of family members | 2 (1, 3) | 1 (0, 2.25) | 2 (1, 3) | 2 (1, 3) | 0.014 |
| Family income last year (CNY ¥) | 100,000 (60,000, 150,000) | 100,000 (52,000, 180,000) | 90,000 (60,000, 138,750) | 100,000 (60,000, 157,500) | 0.576 |
| Hypertension | 0.049 | ||||
| No | 235 (90.4%) | 81 (92.0%) | 78 (95.1%) | 76 (84.4%) | |
| Yes | 25 (9.6%) | 7 (8.0%) | 4 (4.9%) | 14 (15.6%) | |
| Type 2 diabetes | 0.610 | ||||
| No | 248 (95.4%) | 85 (96.6%) | 79 (96.3%) | 84 (93.3%) | |
| Yes | 12 (4.6%) | 3 (3.4%) | 3 (3.7%) | 6 (6.7%) | |
| Cavity | 0.631 | ||||
| No | 224 (86.2%) | 74 (84.1%) | 70 (85.4%) | 80 (88.9%) | |
| Yes | 36 (13.8%) | 14 (15.9%) | 12 (14.6%) | 10 (11.1%) | |
| Combined with EPTB | 0.090 | ||||
| No | 222 (85.4%) | 75 (85.2%) | 65 (79.3%) | 82 (91.1%) | |
| Yes | 38 (14.6%) | 13 (14.8%) | 17 (20.7%) | 8 (8.9%) | |
| Bacteriologically confirmed | 0.002 | ||||
| No | 102 (39.2%) | 37 (42.0%) | 42 (51.2%) | 23 (25.6%) | |
| Yes | 158 (60.8%) | 51 (58.0%) | 40 (48.8%) | 67 (74.4%) | |
Data are n (%) or median (IQR).
EPTB, extrapulmonary TB.
a
p-values were for comparison between three groups using Pearson’s Chi-squared test, Fisher’s exact test, or Kruskal-Wallis rank-sum test.